ID: ALA383465

Max Phase: Preclinical

Molecular Formula: C19H18O5

Molecular Weight: 326.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(C(C)=O)c(O)c(OCc2cccc(C)c2)c2occc12

Standard InChI:  InChI=1S/C19H18O5/c1-11-5-4-6-13(9-11)10-24-19-16(21)15(12(2)20)17(22-3)14-7-8-23-18(14)19/h4-9,21H,10H2,1-3H3

Standard InChI Key:  PEBYQEWZDCISKS-UHFFFAOYSA-N

Associated Targets(non-human)

Voltage-gated potassium channel subunit Kv1.3 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.35Molecular Weight (Monoisotopic): 326.1154AlogP: 4.24#Rotatable Bonds: 5
Polar Surface Area: 68.90Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.56CX Basic pKa: CX LogP: 3.96CX LogD: 3.93
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.71Np Likeness Score: 0.68

References

1. Harvey AJ, Baell JB, Toovey N, Homerick D, Wulff H..  (2006)  A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.,  49  (4): [PMID:16480279] [10.1021/jm050839v]

Source